LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$5.23B
This Quarter Return
+15.02%
1 Year Return
+15.79%
3 Year Return
+49.62%
5 Year Return
+161.51%
10 Year Return
+219.13%
AUM
$5.55B
AUM Growth
+$5.55B
(+10%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
33.64%
Holding
105
New
4
Increased
21
Reduced
62
Closed
8
Top Buys
| 1 |
EFXT
Enerflex
EFXT
|
$44.4M |
| 2 |
FedEx
FDX
|
$26.7M |
| 3 |
GSK
GSK
|
$22.2M |
| 4 |
Rogers Communications
RCI
|
$20M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
$9.32M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$27.5M |
| 2 |
Cenovus Energy
CVE
|
$25M |
| 3 |
Merck
MRK
|
$22.9M |
| 4 |
Canadian Natural Resources
CNQ
|
$20.3M |
| 5 |
Sabesp
SBS
|
$18.6M |
Sector Composition
| 1 | Financials | 29.2% |
| 2 | Communication Services | 16.02% |
| 3 | Energy | 12.23% |
| 4 | Materials | 11.6% |
| 5 | Technology | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
101
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-17,800
| Closed | -$28K |
|
102
Spero Therapeutics
SPRO
$117M
| – | – |
-73,659
| Closed | -$147K |
|
103
Nucor
NUE
$33.3B
| – | – |
-2,150
| Closed | -$230K |
|
104
Heron Therapeutics
HRTX
$204M
| – | – |
-57,200
| Closed | -$241K |
|
105
Fluor
FLR
$6.93B
| – | – |
-270,520
| Closed | -$6.73M |
|